EUVIMEDEUVIMED entdecken
Crossref

Spesolimab Response in a Girl With Acrodermatitis Continua of Hallopeau

Youcong Wang, Li Zhang, Jie Zheng, Xia Li, Lihong Chen

JAMA Dermatology · 01.04.2024 · 160 (4) · 476

DOI: 10.1001/jamadermatol.2023.6349 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Dermatology, erschienen am 01.04.2024. Verfasst von Youcong Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Acrodermatitis, Psoriasis, Exanthema, Skin Diseases, Vesiculobullous. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This case report summarizes the treatment of acrodermatitis continua of Hallopeau with spesolimab in a 9-year-old girl.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcrodermatitisPsoriasisExanthemaSkin Diseases, VesiculobullousFemaleHumansAntibodies, Monoclonal, Humanized

Substanzen

spesolimabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Dermatology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Zitieren

APA

Wang, Y., Zhang, L., Zheng, J., Li, X., & Chen, L. (2024). Spesolimab Response in a Girl With Acrodermatitis Continua of Hallopeau. JAMA Dermatology, 160(4), 476. https://doi.org/10.1001/jamadermatol.2023.6349

Vancouver

Wang Y, Zhang L, Zheng J, Li X, Chen L. Spesolimab Response in a Girl With Acrodermatitis Continua of Hallopeau. JAMA Dermatology. 2024;160(4):476. doi:10.1001/jamadermatol.2023.6349

BibTeX
@article{Wang2024,
  author = {Wang, Youcong and Zhang, Li and Zheng, Jie and Li, Xia and Chen, Lihong},
  title = {Spesolimab Response in a Girl With Acrodermatitis Continua of Hallopeau},
  journal = {JAMA Dermatology},
  year = {2024},
  volume = {160},
  number = {4},
  pages = {476},
  doi = {10.1001/jamadermatol.2023.6349}
}
Kostenlos starten →